Wolverine Trading, LLC Alkermes Plc. Call Options Transaction History

Wolverine Trading, LLC

$103 Billion
Q4 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $66,820 - $81,796	2,600 Added 33.77%	10,300 $296,000
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $135,759 - $168,445	-5,900 Reduced 43.38%	7,700 $215,000
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $164,791 - $193,404	-7,100 Reduced 34.3%	13,600 $327,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $546,480 - $673,992	20,700 New	20,700 $560,000
Q3 2023 Nov 15, 2023	BUY	$27.17 - $31.97 $301,587 - $354,867	11,100 New	11,100 $310,000
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $174,639 - $200,238	6,900 Added 65.09%	17,500 $487,000
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $232,564 - $278,144	10,600 New	10,600 $277,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $84,480 - $97,728	-3,200 Reduced 31.68%	6,900 $209,000
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $136,113 - $165,141	-5,900 Reduced 36.88%	10,100 $268,000
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $122,379 - $182,856	5,700 Added 55.34%	16,000 $374,000
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $27,315 - $34,800	-1,500 Reduced 12.71%	10,300 $193,000
Q4 2020 Feb 12, 2021	BUY	$15.39 - $22.1 $181,602 - $260,780	11,800 New	11,800 $241,000
Q1 2020 May 11, 2020	SELL	$13.06 - $21.24 $137,130 - $223,019	-10,500 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$17.29 - $21.74 $181,545 - $228,269	10,500 New	10,500 $211,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $308,258 - $383,624	-15,800 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$21.47 - $37.33 $113,791 - $197,849	-5,300 Reduced 25.12%	15,800 $356,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $1.05 Million - $1.35 Million	-36,900 Reduced 63.62%	21,100 $770,000
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $19,558 - $31,227	700 Added 1.22%	58,000 $1.65 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $2.21 Million - $2.64 Million	57,300 New	57,300 $2.43 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $1.31 Million - $1.64 Million	-24,400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $1.16 Million - $1.35 Million	24,400	24,400 $1.34 Million

Others Institutions Holding ALKS

# of Institutions

372

Shares Held

175M

Call Options Held

140K

Put Options Held

143K

Black Rock Inc. New York, NY

29.1M
Shares

$1.04 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

18.5M
Shares

$664 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.3M
Shares

$440 Million
0.04% of portfolio
State Street Corp Boston, MA

8.81M
Shares

$316 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.56M
Shares

$271 Million
3.55% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account